APA-referens

Dorff, T. B., Longmate, J., Pal, S. K., Stadler, W., Fishman, M., Vaishampayan, U., . . . Lara, P. N. (2017). Bevacizumab alone or in combination with TRC105 for refractory metastatic renal cell cancer patients. Cancer.

Chicago-stil citat

Dorff, Tanya B., et al. "Bevacizumab Alone or in Combination With TRC105 for Refractory Metastatic Renal Cell Cancer Patients." Cancer 2017.

MLA-referens

Dorff, Tanya B., et al. "Bevacizumab Alone or in Combination With TRC105 for Refractory Metastatic Renal Cell Cancer Patients." Cancer 2017.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.